Macrocure, Ltd. (NASDAQ:MCUR) Still Surging One Month After Merger With Leap Therapeutics

Macrocure, Ltd. (NASDAQ:MCUR) Still Surging One Month After Merger With Leap Therapeutics

Shares of Macrocure, Ltd. (NASDAQ:MCUR) are still advancing significantly one month out from merger with Leap Therapeutics. Shares of Macrocure Ltd. MCUR shot up 66.1% after the company announced that it has signed a definitive merger agreement with privately held company, Leap Therapeutics, Inc. After the completion of the deal, Leap Therapeutics will become a publicly traded company, with Macrocure operating as its wholly owned subsidiary. Leap Therapeutics will apply […]

Read More ˃
Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) Fall Following Report

Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) Fall Following Report

Biopharmaceutical company, Peregrine Pharmaceuticals (NASDAQ:PPHM has reported that the that top-line data from the Phase III SUNRISE trial of bavituximab in patients with previously treated locally advanced or metastatic non-squamous non-small cell lung cancer were presented in an oral presentation at the European Society for Medical Oncology 2016 Congress. — Company Has Identified Beta-2 Glycoprotein-1 (β2GP1) as a Biomarker that Correlates with Statistically Significant Improvement in Overall Survival for Patients […]

Read More ˃
PhotoMedex, Inc. (NASDAQ:PHMD) Acquired By ICTV Brands (CSE:ITY) for $9.5M, Stocks Advance on News

PhotoMedex, Inc. (NASDAQ:PHMD) Acquired By ICTV Brands (CSE:ITY) for $9.5M, Stocks Advance on News

Marketing and branding health company, ICTV Brands (CSE:ITY) announces an agreement to acquire the consumer products business of PhotoMedex, Inc. (NASDAQ:PHMD) for $9.5 million. A Wayne direct response marketing and branding company specializing in the health, wellness and beauty sector, has signed a definitive agreement to acquire the consumer products business of PhotoMedex Inc. — led by its line of no!no! hair removal products — for $9.5 million. ICTV Brands […]

Read More ˃
How Will Investors Respond to News that Aemetis, Inc. (NASDAQ:AMTX) Awards Stock Option

How Will Investors Respond to News that Aemetis, Inc. (NASDAQ:AMTX) Awards Stock Option

Renewable Fuels and biochemical company, Aemetis, Inc. (NASDAQ:AMTX), announces that it has awarded a nonqualified stock option for the purchase of 12,000 shares of common stock at an exercise price of $1.63 CUPERTINO, CA / ACCESSWIRE / September 30, 2016 / Aemetis, Inc. (AMTX), On August 18, 2016, a nonqualified stock option for the purchase of 12,000 shares of common stock at an exercise price of $1.63 (the closing price […]

Read More ˃
Pepsico and Senomyx, Inc. (NASDAQ:SNMX) Announce Three-Year Extension of the “Sweet Taste” Program, How Will the Stock Price Respond?

Pepsico and Senomyx, Inc. (NASDAQ:SNMX) Announce Three-Year Extension of the “Sweet Taste” Program, How Will the Stock Price Respond?

Leading taste science company, Senomyx, Inc. (NASDAQ:SNMX), announces that it has extended its Sweet Taste Program with PepsiCo for another three years. SAN DIEGO, Sept. 30, 2016 /PRNewswire/ — Senomyx, Inc. (SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that it has amended and restated its Sweet Taste Program collaboration agreement […]

Read More ˃
Analysts Strong on ABM Industries, Inc. (NYSE:ABM)

Analysts Strong on ABM Industries, Inc. (NYSE:ABM)

Analyst has recently weighed in on ABM Industries, Inc. (NYSE:ABM), issuing notes to Andrew J. Wittmann, of Baird Equity Research Facility Services remains their Outperform rating on the stock on September 03, 2015 with a $35.00 price target, or 16.67% upside to the last closing price. F3Q15 earnings presented a “kitchen sink” quarter, with new management announcing key tenets of the company’s comprehensive strategic review, but also unwinding previous margin-enhancing […]

Read More ˃
MorningStar Cuts Fair Value Estimate to $23 from $25 on Micron Technology, Inc.(NASDAQ:MU)

MorningStar Cuts Fair Value Estimate to $23 from $25 on Micron Technology, Inc.(NASDAQ:MU)

Equity Analyst Abhinav Davuluri of Investment Research Firm MorningStar issued a research report called ”2015 Headwins Expected to Persist in 2016 for Micron Technology, Inc.(NASDAQ:MU); Cutting Fair Value Estimate to $23 According to the report ”Micron reported fiscal fourth-quarter results that were in line with our expectations. PC-related DRAM once again served as a drag on gross margin; however, management stressed that non-PC market DRAM (mobile, server, etc.) demand was […]

Read More ˃
Here is Why MorningStar Updated Forecasts and Estimates on Exelixis, Inc.(NASDAQ:EXEL)

Here is Why MorningStar Updated Forecasts and Estimates on Exelixis, Inc.(NASDAQ:EXEL)

Equity Analysts Karen Andersen, CFA and Stefan Quenneville, CFA of Investment Research Firm MorningStar issued a research report called ”Pricing Concerns in Pharma and Biotech Industries Creates Some Buying Opportunities and updated star rating on Exelixis, Inc.(NASDAQ:EXEL) According to the report ”Exelixis is best known for its R&D prowess for discovering targeted cancer drugs, which has resulted in a pipeline of oncology products partnered with multiple Big Pharma players. The […]

Read More ˃
MorningStar Updates Forecasts and Estimates on Gilead Sciences, Inc.(NASDAQ:GILD) Here is Why

MorningStar Updates Forecasts and Estimates on Gilead Sciences, Inc.(NASDAQ:GILD) Here is Why

Equity Analysts Karen Andersen, CFA and Damien Conover, CFA of Investment Research Firm MorningStar issued a research report and updated Forecasts and Estimates on Gilead Sciences, Inc.(NASDAQ:GILD) On October 2. According to the report ”Gilead’s focus on infectious disease has paid off in spades. With a small salesforce, inexpensive manufacturing, and selective research and development, it generates stellar profit margins, and the firm’s pipeline is extending its reach into other […]

Read More ˃
Sterne Agee Initiates Buy on GoPro Inc (NASDAQ:GPRO) Sees 50% Upside for the Stock

Sterne Agee Initiates Buy on GoPro Inc (NASDAQ:GPRO) Sees 50% Upside for the Stock

In a research report issued September 28 Sterne Agee analysts Rob Cihra and Edison Yu initiated coverage on shares of GoPro Inc(NASDAQ:GPRO) with a buy rating and price target of $45 which represents a potential upside of 50% from where the stock is currently trading. Cihra and Yu noted ”Pulling this together, we disagree with one of the GPRO bear cases from day 1, namely that other consumer electronics companies […]

Read More ˃